Drug hypersensitivity: Flare-up reactions, cross-reactivity and multiple drug hypersensitivity

Journal of Dermatology

Volumn 38, Issue 3, 2011, Pages 216-221

  Pichler, Werner J ^a,b   Daubner, Barbara ^a,b   Kawabata, Tom ^c  

^a Adverse Drug Reactions Analysis and Consulting (ADR AC) GmbH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c PFIZER INC   (United States)

Author keywords

cross reactivity; drug hypersensitivity; flare up; multiple drug hypersensitivity

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BUPIVACAINE; CEPHALOSPORIN; CYTOKINE; IMMUNOGLOBULIN E; LIDOCAINE; MEPIVACAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN; PIPERACILLIN; PREDNISOLONE; STEROID; SULFAMETHOXAZOLE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELLULAR IMMUNITY; CHEMOSENSITIZATION; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRESS SYNDROME; DRUG CROSS REACTIVITY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG RECEPTOR BINDING; DRUG SUBSTITUTION; ERYTHRODERMA; HUMAN; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MOLECULAR INTERACTION; PROTEIN BLOOD LEVEL; RASH; RECEPTOR AFFINITY; RISK FACTOR; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS;

CROSS REACTIONS; DRUG HYPERSENSITIVITY; HUMANS; T-LYMPHOCYTES;

EID: 79952032148     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01142.x     Document Type: Article

References (25)

1. Landsteiner K, Jacobs J,. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935; 61: 643-656.
2. Weltzien HU, Padovan E,. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110: 203-206. (Pubitemid 28144591)
3. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK,. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 2000; 23: 483-507. (Pubitemid 32001512)
4. Pichler WJ,. Drug Hypersensitivity in Allergy and Allergic Diseases. (edited by, Kay B, Kaplan A, Bousquet J, Holt P,). Oxford: Wiley-Blackwell 2008.
5. Pichler WJ,. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683-693.
6. Pichler WJ,. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2: 301-305. (Pubitemid 36869638)
7. Pichler WJ, Beeler A, Keller M, et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 2006; 55: 17-25.
8. Pichler WJ,. Direct T-cell stimulations by drugs - bypassing the innate immune system. Toxicology 2005; 209: 95-100. (Pubitemid 40568634)
9. Geiger R, Duhen T, Lanzavecchia A, Sallusto F,. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 2009; 206 (7): 1525-1534.
10. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128 (1): 35-44. (Pubitemid 350249390)
11. Hirahara K, Kano Y, Mitsuyama Y, Takahashi R, Kimishima M, Shiohara T,. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions. Clin Exp Dermatol 2010; 35: 863-868.
12. Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31 (9): 1398-1408. (Pubitemid 32823877)
13. Kano Y, Shiohara T,. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29: 481-501.
14. Mennicke M, Zawodniak A, Keller M, et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 2009; 9 (9): 2197-2202.
15. Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpes virus 6 replication in vitro. Eur J Dermatol 2010; 20 (1): 68-73.
16. Beeler A, Engler O, Gerber BO, Pichler WJ,. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006; 117: 455-462. (Pubitemid 43190160)
17. Mauri-Hellweg D, Zanni M, Frei E, et al. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol 1996; 157 (3): 1071-1079.
18. Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine-specific T cells. J Immunol 1997; 158 (3): 1139-1148. (Pubitemid 127469935)
19. Zanni MP, von Greyerz S, Hari Y, Schnyder B, Pichler WJ,. Recognition of local anesthetics by alphabeta+ T cells. J Invest Dermatol 1999; 112 (2): 197-204. (Pubitemid 29061976)
20. Sullivan TJ, Remedios C, Ong MD, Gilliam LK,. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989; 83: 270.
21. Asero R,. Multiple drug allergy syndrome: a distinct clinical entity. Curr Allergy Rep 2001; 1 (1): 18-22.
22. Gex-Collet C, Helbling A, Pichler WJ,. Multiple drug hypersensitivity - proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol 2005; 15 (4): 293-296. (Pubitemid 43275828)
23. Neukomm CB, Yawalkar N, Helbling A, Pichler WJ,. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001; 11 (4): 275-285.
24. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T,. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182: 8071-8079.
25. Kanny G, Pichler W, Morisset M, et al. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005; 115 (1): 179-185. (Pubitemid 40075440)